AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
HYOSCINE BUTYL BROMIDE
9 registrations across 4 African markets— 6 active
Markets with HYOSCINE BUTYL BROMIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BUSCOREN 10 MG TAB Tablets | 🇷🇼Rwanda | RENE INDUSTRIES LTD | active | Aug 2029 |
| ORASPAS 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2024 |
| DUXCOSPAN 10MG TABLETS TABLETS | 🇲🇼Malawi | — | expired | Mar 2023 |
| HYOSCINE_BUTYL_BROMIDE 10MG TABLET TABLET | 🇲🇼Malawi | — | expired | Mar 2023 |
| HYOSCINE BUTYL
BROMIDE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | AFRICURE PHARMACEUTICA LS (INDIA) PRIVATELIMITED | active | — |
| HYOSCINE BUTYL
BROMIDE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | AFRICURE PHARMACEUTICA LS (INDIA) PRIVATELIMITED | active | — |
| HYOSPAS Solution for injection | 🇹🇿Tanzania | Neomedic Limited | active | — |
| HYOSCINE BUTYL
BROMIDE ORAL SOLID
ORDINARY TABLETS | 🇺🇬Uganda | AFRICURE PHARMACEUTICA LS (INDIA) PRIVATELIMITED | active | — |
| HYOSCINE BUTYL
BROMIDE ORAL SOLID
ORDINARY
TABLETS | 🇺🇬Uganda | AFRICURE PHARMACEUTICA LS (INDIA) PRIVATELIMITED | active | — |
HYOSCINE BUTYL BROMIDE in Africa — Regulatory Overview
HYOSCINE BUTYL BROMIDE is registered across 4 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Rwanda, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 6 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.